Treatment of multiple sclerosis using interferon-tau

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

IPC codes

A61K 38/21 (2006.01) A61P 37/00 (2006.01)

Type

Patent

Patent number

CA 2632024

Description

Methods of treating an autoimmune condition by administering IFN.tau. are described. IFN.tau. is administered orally at a dose sufficient to achieve obtain a desired clinical endpoint, such as a reduction in new contrast- enhanced brain lesions in multiple sclerosis patients.

La présente invention concerne des procédés de traitement d'une maladie auto-immune consistant en l'administration d'IFN.tau.. L'IFN.tau. est administré oralement à une dose suffisante pour obtenir un critère d'évaluation clinique souhaité, notamment une réduction de nouvelles lésions cérébrales à contraste rehaussé chez des patients atteints de sclérose en plaques

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of multiple sclerosis using interferon-tau does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of multiple sclerosis using interferon-tau, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis using interferon-tau will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1882742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.